Impact of antimicrobial resistance on sustainable development goals and the integrated strategies for meeting environmental and socio‐economic targets

Abstract

AbstractThe pattern in mortality and morbidity associated with infectious diseases can be linked to different variables. However, advancements in sanitation and public health, as well as the development of vaccines and antibiotics are among the most relevant of these factors. The emergence of antimicrobial resistance is a natural and unavoidable result of evolutionary adaptation of pathogenic microbes and their exposure to these chemical agents. The widespread use of these medications has substantially accelerated up this process. This review investigates the mechanism through which sustainable development goals are impacted by AMR. It also examines methods through which the issue might be better integrated into the policy‐making frameworks of international organizations. The necessity of effective antibiotics during the treatment of infections and medical care is evaluated with an analysis on AMR influencing the ecological, societal, and economic interests that are outlined in the framework for the SDGs. Emphasis is on the necessity for strengthening the scientific community through international collaboration and accountability of distribution especially after the COVID‐19 pandemic. This offers initiatives toward a deeper participation of low and middle‐income countries with high income countries to create channels for national and local governance for executing policies combatting AMR.